human-immunodeficiency-virus-hiv

Documents about human-immunodeficiency-virus-hiv

• HCV/HIV Coinfection: Antiviral Therapy and Fibrosis#915202ClinicalTrials.gov
• Human Immunodeficiency Virus (HIV)#339164Southampton
• ICVAX as a HIV Therapeutic DNA Vaccine#143663ClinicalTrials.gov
• A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)#838597ClinicalTrials.gov
• An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study#842673ClinicalTrials.gov
• Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults#871319ClinicalTrials.gov
• PRO 140 for Human Immunodeficiency Virus#1008969ClinicalTrials.gov
• Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women#848427ClinicalTrials.gov
• Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men#826954ClinicalTrials.gov
• The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo#850096ClinicalTrials.gov
• HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong#28427ClinicalTrials.gov
• PRO 140 for Human Immunodeficiency Virus Infection#890829ClinicalTrials.gov
• Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older#891936ClinicalTrials.gov
• Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults#1007759ClinicalTrials.gov
• Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients#915918ClinicalTrials.gov
• Observational Study of HIV-associated Neurocognitive Disorder#832410ClinicalTrials.gov
• Regional Differences in Human Immunodeficiency Virus (HIV) Testing#858222ClinicalTrials.gov
• HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy#831606ClinicalTrials.gov
• Reality Check: An HIV Risk Reduction Serial Drama#873507ClinicalTrials.gov
• Pre-Exposure Prophylaxis Using TMC278LA#806664ClinicalTrials.gov
• A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected Children#887036ClinicalTrials.gov
• Alcohol Monitor Validation#1008746ClinicalTrials.gov
• Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay#882057ClinicalTrials.gov
• Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)#802473ClinicalTrials.gov
• A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)#830149ClinicalTrials.gov
• Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)#226329ClinicalTrials.gov
• Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients#826842ClinicalTrials.gov
• GSK1349572 Relative Bioavailability Study#874734ClinicalTrials.gov
• Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection#857957ClinicalTrials.gov
• Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men#800977ClinicalTrials.gov
• Tissue Drug Levels of HIV Medications#893137ClinicalTrials.gov
• MyPEEPS Mobile for Young Transgender Men#908782ClinicalTrials.gov
• Mathematical Modeling for Human Immunodeficiency Virus (HIV) Transmission using Generating Function Approach#957009SU+ Digital Repository
• Treatment of Oral Warts in HIV+ Patients#841796ClinicalTrials.gov
• Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)#900039ClinicalTrials.gov
• Text Education About Cardiovascular Health and HIV (TEACH-HIV)#858495ClinicalTrials.gov
• A Combination HIV Prevention Strategy for Young Women at Risk for HIV#979015ClinicalTrials.gov
• Combating Related Epidemics in HCV#881744ClinicalTrials.gov
• A Clinical Phase 3 Trial of VLA1553 in Adult Participants with Human Immunodeficiency Virus (HIV)#435785ClinicalTrials.gov
• The Effect of Ixazomib on the Latent HIV Reservoir#856249ClinicalTrials.gov
• Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection#870184ClinicalTrials.gov
• Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice#916780ClinicalTrials.gov
• Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients#967047ClinicalTrials.gov
• A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1#847283ClinicalTrials.gov
• Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection#831499ClinicalTrials.gov
• Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis#805928ClinicalTrials.gov
• Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women#148572ClinicalTrials.gov
• Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism#854415ClinicalTrials.gov
• Characteristics and Outcomes of TB and HIV Co-infections#907350ClinicalTrials.gov
• Guidelines for nursing management of people infected with human immunodeficiency virus (HIV)#466862WHO IRIS